Drug Discovery and Drug Development: The Indian Narrative
Editat de Madhu Dikshiten Limba Engleză Paperback – 11 feb 2022
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 863.14 lei 38-44 zile | |
Springer Nature Singapore – 11 feb 2022 | 863.14 lei 38-44 zile | |
Hardback (1) | 895.26 lei 3-5 săpt. | |
Springer Nature Singapore – 11 feb 2021 | 895.26 lei 3-5 săpt. |
Preț: 863.14 lei
Preț vechi: 908.57 lei
-5% Nou
Puncte Express: 1295
Preț estimativ în valută:
165.24€ • 171.76$ • 137.00£
165.24€ • 171.76$ • 137.00£
Carte tipărită la comandă
Livrare economică 01-07 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789811580048
ISBN-10: 9811580049
Pagini: 376
Ilustrații: XIII, 376 p. 191 illus., 44 illus. in color.
Dimensiuni: 155 x 235 mm
Ediția:1st ed. 2021
Editura: Springer Nature Singapore
Colecția Springer
Locul publicării:Singapore, Singapore
ISBN-10: 9811580049
Pagini: 376
Ilustrații: XIII, 376 p. 191 illus., 44 illus. in color.
Dimensiuni: 155 x 235 mm
Ediția:1st ed. 2021
Editura: Springer Nature Singapore
Colecția Springer
Locul publicării:Singapore, Singapore
Cuprins
Chapter 1. Traditional Medical System (TMS) for Sustainable Healthcare in India.- Chapter 2. Modern Drug Discovery and Development for TB- The India Narrative.- Chapter 3. Indian Discovery Effort in the Quest of Novel Antibiotics.- Chapter 4. New Drug Discovery and Development in India to Counter Malaria.- Chapter 5. Modern Drug Discovery and Development in the area of Leishmaniasis.- Chapter 6. Modern Drug Discovery and Development: Diabetes and lifestyle disorders Part I – Introduction to Diabetes and Prevalence in India.- Chapter 7. Modern Drug Discovery and Development: Diabetes and lifestyle disorder Part II Type 2 Diabetes Mellitus: Marketed drugs and mechanisms.- Chapter 8. Modern Drug Discovery and Development: Diabetes and lifestyle disorders Part III Anti-diabetes research in India: Contributions from industrial organizations.- Chapter 9. Modern Drug Discovery and Development: Diabetes and lifestyle disorders Part IV Indian Academia Tryst with Cardio-metabolic Drug Discovery and Development.- Chapter 10. Modern drug discovery and development in the area of Cancer: Indian context.- Chapter 11. Biopharmaceutical development in India: recommendations on collaboration and innovation to enable affordable healthcare.- Chapter 12. Regulatory requirements and Quality Standards in India’s Clinical Trials Journey.- Chapter 13. Indian Pharma Perspective: New Drug Discovery and Development- Indian Pharmaceutical Industry.
Notă biografică
Dr Madhu Dikshit, a highly respected researcher and former Director of the CSIR-Central Drug Research Institute, Lucknow, India, has made significant contributions to the general area of Molecular Pharmacology with a special interest in redox biology. Dr Dikshit’s research has impacted the area of neutrophil biology by enhancing our understanding of e.g. chemotaxis, phagocytosis, apoptosis and also differentiation. Her pioneering work has helped identify the molecular mechanisms involved in the translocation of Nitric Oxide Synthase to the phagosomal compartment and the inflammatory potential of neutrophil extracellular traps. At the CSIR-CDRI, she initiated and led the successful anti-thrombotic drug discovery program, in the context of which two new chemical entities advanced to the pre-clinical stage and one has recently received approval for Phase I clinical trials. Dr Dikshit has published more than 170 papers in peer-reviewed journals, holds eight patents and has supervised more than 30 PhD students. Presently she is the National Chair at Translational Health Sciences & Technology Institute (THSTI), Faridabad and heads its Non-Communicable Disease Program.
Textul de pe ultima copertă
Over the years, India has attained a prominent global position in the manufacture of Generic Drugs. This success can be attributed to its synthetic organic chemistry and chemical engineering strengths, nurtured by the timely policies of the Government of India. However, breakthrough successes in New Drug Discovery have remained elusive, despite the brilliant and sustained efforts of many Indian researchers and Pharma establishments. The Indian National Science Academy thought it appropriate to document India’s New Drug Discovery Research (NDDR) journey to date. Gathering contributions from prominent researchers in the Indian Pharma Industry and Academia, this book highlights their efforts, achievements, and the status quo of Indian NDDR.
Caracteristici
Discusses the successes and critically assesses the failures of new drug discovery efforts Shares insights and updates on drug development in a wide range of areas such as metabolic diseases, parasitic diseases, cancer, and microbial diseases Offers an inside view of the history of drug discovery in the Indian pharmaceutical industry